Global Xerostomia Therapeutics Market Size, Share, Industry Report, 2023-2028
5 mins read

Global Xerostomia Therapeutics Market Size, Share, Industry Report, 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global xerostomia therapeutics market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Xerostomia Therapeutics

Xerostomia dry mouth disease therapeutics refer to a range of medical treatments and interventions that focus on alleviating the symptoms and addressing the underlying causes of xerostomia, which is commonly known as dry mouth disease. They are cost-effective, convenient to use, and widely available as saliva stimulating medications, saliva substitutes, oral lubricants, chewing gum and lozenges, and prescription toothpaste and mouthwash. They can help stimulate the production of saliva in individuals and provide relief from dry mouth symptoms while improving overall oral comfort. They prevent dental issues, such as cavities, tooth decay, and gum disease, and maintain oral health. As they are beneficial in maintaining oral moisture and alleviating dryness and discomfort, the demand for xerostomia dry mouth disease therapeutics is increasing across the globe.   

How Big Is the Xerostomia Therapeutics Market?

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 714 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 893 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

Request Sample Copy of This Report:

What are the growth prospects and trends in the xerostomia therapeutics industry?

At present, the rising prevalence of xerostomia among the masses represents one of the key factors impelling the market growth. Moreover, the increasing development of innovative and patient-friendly treatment options is strengthening the market growth. Apart from this, the escalating demand for sustainable and eco-friendly solutions that reduce environmental impact, along with the rising focus on enhancing patient comfort and quality of life, is positively influencing the market.

In addition, increasing preferences for natural and bio-based ingredients in xerostomia therapeutics that are chemical-free are contributing to the market growth. Besides this, advancements in drug delivery systems and formulation technologies for more effective and convenient dry mouth therapeutics are supporting the growth of the market. Furthermore, the rising awareness about the early diagnosis of xerostomia among individuals is providing lucrative growth opportunities to industry investors.

In line with this, the rising focus on dental hygiene and preventive care among people is propelling the market growth. Additionally, the growing demand for xerostomia dry mouth disease therapeutics among the geriatric population, as they are more prone to dry mouth, is offering a favorable market outlook.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Artificial Saliva/Saliva Substitutes
  • Salivary Stimulants

Breakup by Drug Type:

  • OTC
  • Prescription

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal


Pharmaceutical Drug Delivery Market Share, Industry Report And Revenue Forecast 2023-2028
Reinforcement Materials Market Share, Industry Report And Forecast 2023-2028
Solid State Drive Market Share, Growth, Revenue Forecast 2023-2028
Tape Storage Market Size, Share, Industry Growth 2023-2028